Redmile Group, LLC sold $52k of ADCT
owner at ADC Therapeutics SA. 25,352 shares at an average of $2.07, traded Dec 4, 2024, filed Dec 6, 2024.
Score components
- +12Role10% owner
- +7Trade size$52k at market
- 0Share of holdings soldSold 0.2% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-126422, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 4, 2024 | SOpen-market sale Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | -25,352 | $2.07 | $52k | 15,566,731 | Dec 6, 2024 |
| Dec 4, 2024 | JOther Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | -50,672 | $2.07 | $105k | 15,516,059 | Dec 6, 2024 |
| Dec 4, 2024 | JOther Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | +50,672 | $2.07 | $105k | 15,566,731 | Dec 6, 2024 |
| Dec 4, 2024 | JOther Common Shares, par value CHF 0.08 per share | +50,672 | $2.07 | $105k | 13,045,712 | Dec 6, 2024 |
| Dec 4, 2024 | JOther Pre-Funded Warrantsderivativeindirect: See Footnotes | -26,656 | $2.07 | $55k | 8,136,609 | Dec 6, 2024 |
| Dec 4, 2024 | JOther Pre-Funded Warrantsderivativeindirect: See Footnotes | +26,656 | $2.07 | $55k | 8,163,265 | Dec 6, 2024 |
| Dec 4, 2024 | JOther Pre-Funded Warrantsderivative | +26,656 | $2.07 | $55k | 6,133,837 | Dec 6, 2024 |
Related signals
Other insiders at ADC Therapeutics SA and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | ADCTbuy ADC Therapeutics SA | Redmile Group, LLC owner | $609k 200,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.